| Name | GNF2133 |
|---|---|
| Synonyms |
4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-cboxamide
GNF2133, 10 mM in DMSO β-cell,RIP-DTA mice,Inhibitor,insulin secretion,GNF2133,inhibit,Dual specificity tyrosine regulated kinase,glucose disposal,Dual specificity tyrosine phosphorylation regulated kinase,CD-1 mice,GNF 2133,DYRK,GNF-2133,orally active 4-ethyl-N-{4-[1-(oxan-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl}piperazine-1-cboxamide 1-Piperazinecboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl] |
| Description | GNF2133 is a selective DYRK1A inhibitor with an IC50 value of 6 nM. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H30N6O2 |
|---|---|
| Molecular Weight | 434.53 |